"L'Institut Sainte-Catherine est un établissement de santé privé d’intérêt collectif en Avignon spécialisé dans le dépistage et le traitement des cancers. Il est doté de 88 lits d’hospitalisation, 38 places d’hôpital de jour."

During the past decade, Institut Sainte-Catherine; Oncologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut Sainte-Catherine; Oncologie" are "Breast Cancer" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Institut Sainte-Catherine; Oncologie" in a lesser frequency.

Most popular intervention types in "Institut Sainte-Catherine; Oncologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Enzalutamide" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Sainte-Catherine; Oncologie" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Sainte-Catherine; Oncologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institut Sainte-Catherine; Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Sainte-Catherine; Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".